Table 1 Clinicopathological characteristics of patients with cervical cancer in primary cohort and validation cohort.
From: Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer
Characteristic | Primary Cohort (n = 328) | Validation Cohort (n = 130) | χ2 | P | ||
|---|---|---|---|---|---|---|
No. of Patients | % | No. of Patients | % | |||
Age | 0.29 | 0.590 | ||||
≤45 | 170 | 51.8 | 71 | 54.6 | ||
>45 | 158 | 48.2 | 59 | 45.4 | ||
Histological grade | 15.66 | 0.001 | ||||
G1 | 36 | 11.0 | 12 | 9.2 | ||
G2 | 141 | 43.0 | 82 | 63.1 | ||
G3 | 151 | 46.0 | 36 | 27.7 | ||
Tumor size | 0.99 | 0.319 | ||||
≤4 | 180 | 54.9 | 78 | 60.0 | ||
>4 | 148 | 45.1 | 52 | 40.0 | ||
Lymph node metastasis | 1.07 | 0.301 | ||||
Negative | 257 | 78.4 | 96 | 73.8 | ||
Positive | 71 | 21.6 | 34 | 26.2 | ||
Lymphovascular invasion | 1.78 | 0.182 | ||||
No | 288 | 87.8 | 108 | 83.1 | ||
Yes | 40 | 12.2 | 22 | 16.9 | ||
FIGO stage | 0.02 | 0.99 | ||||
IA | 84 | 25.6 | 34 | 26.2 | ||
IB | 174 | 53.0 | 68 | 52.3 | ||
IIA | 70 | 21.3 | 28 | 21.5 | ||
